Results 141 to 150 of about 777,596 (195)

ATP1A1/BCL2L1 predicts the response of myelomonocytic and monocytic acute myeloid leukemia to cardiac glycosides. [PDF]

open access: yesLeukemia
Cerella C   +12 more
europepmc   +1 more source

Identification and characterization of Cardiac Glycosides as senolytic compounds. [PDF]

open access: yesNat Commun, 2019
Triana-Martínez F   +26 more
europepmc   +1 more source

Cardiac glycosides: Looking beyond heart failure and atrial fibrillation.

open access: yesIndian J Pharmacol
Omole JG   +8 more
europepmc   +1 more source

Preconditioning and Postconditioning by Cardiac Glycosides in the Mouse Heart. [PDF]

open access: yesJ Cardiovasc Pharmacol, 2018
Duan Q   +5 more
europepmc   +1 more source

The cardiac glycosides.

open access: yesNorth Carolina medical journal, 2010
R A, BROOME, E S, ORGAIN
openaire   +1 more source

Cardiac Glycosides

New England Journal of Medicine, 1962
Dale G Friend, D G Friend
exaly   +4 more sources

Vanadate and Cardiac Glycosides.

Lancet, The, 1983
Ewen Macdonald, E Macdonald
exaly   +3 more sources

Cardiac Glycosides as Senolytic Compounds

open access: yesTrends in Molecular Medicine, 2020
International audienceThe identification of senolytics, compounds that eliminate senescent cells, is presently a key priority given their therapeutic promise in cancer and aging-associated diseases. Two recent papers by Triana-Martínez et al.
David Bernard, Nadine Martin
exaly   +2 more sources

Home - About - Disclaimer - Privacy